Exosomes derived from human dental pulp stem cells increase flap survival with ischemia-reperfusion injuries
Abstract
Aim: To investigate the effect of hDPSC-Exos in flap I/R injury, a condition in which tissue damage increases after blood flow is restored to the flap after ischemia. Materials & methods: HUVECs were used to investigate the influences and mechanisms of hDPSC-Exos on cell proliferation and migration. A rat model was established to verify the role of hDPSC-Exos in flap I/R injuries in vivo. Results: hDPSC-Exos promoted the proliferation, migration and tube formation of HUVECs in a dose-dependent way by activating PI3K/AKT signaling pathway, and improved the survival and microvessel density of the flap and suppressed epithelial cell apoptosis. Conclusion: hDPSC-Exos can enhance flap repair after I/R injury. This process may be mediated by the activation of PI3K/AKT signaling pathway.
Graphical abstract
Plain language summary
Skin flap transplantation is one of the most important methods of repairing refractory wounds and organ reconstruction. I/R injury and insufficiency of neovascularization significantly affect the survival of flaps. Human dental pulp stem cells (hDPSCs) are a type of mesenchymal stem cells (MSCs) present in dental pulp tissue that have attracted increasing attention. They can play a repair role in a variety of ischemic injuries and neovascularization. Exosomes are important paracrine mediators between MSCs and target cells, containing a variety of proteins, mRNA and miRNA. Recent studies have shown that some exosomes derived from MSCs can improve I/R injury, promote angiogenesis and inhibit apoptosis. This study confirmed that hDPSC-Exos could promote the proliferation, migration and tubule formation of vein endothelial cells in a dose-dependent manner. Inhibition of PI3K/AKT signaling pathway can reduce the above promoting effects, suggesting that these processes may depend on the activation of PI3K/AKT signaling pathway. In the rat model, hDPSC-Exos can significantly improve the survival rate and microvessel density of flaps, and inhibit epithelial cell apoptosis.
Papers of special note have been highlighted as: • of interest; •• of considerable interest
References
- 1. . Repair of cutaneous defects after skin cancer surgery. Recent results in cancer research. Fortschritte der Krebsforschung. Progres dans les recherches sur le cancer 160, 225–233 (2002).
- 2. A Systematic Review and Overview of Flap Reconstructive Techniques for Nasal Skin Defects. Facial Plast. Surg. Aesthet. Med. 23(6), 476–481 (2021).
- 3. Improved survival of murine island skin flaps by prevention of reperfusion injury. Plast. Reconstr. Surg. 123(5), 1431–1439 (2009).
- 4. . Growth factors and flap survival. Microsurgery 24(3), 162–167 (2004).
- 5. . Insight into the Role of Dental Pulp Stem Cells in Regenerative Therapy. Biology (Basel) 9(7), 160 (2020).
- 6. Transplantation of human dental pulp stem cells ameliorates brain damage following acute cerebral ischemia. Biomed. Pharmacother. 108, 1005–1014 (2018).
- 7. Dental Pulp Mesenchymal Stem Cells Attenuate Limb Ischemia via Promoting Capillary Proliferation and Collateral Development in a Preclinical Model. Stem Cells Int 2021, 5585255 (2021).
- 8. Human dental pulp stem cells improve left ventricular function, induce angiogenesis, and reduce infarct size in rats with acute myocardial infarction. Stem Cells 26(3), 638–645 (2008).
- 9. Therapeutic potential of dental pulp stem cells and their derivatives: insights from basic research toward clinical applications. World J. Stem Cells 14(7), 435–452 (2022).
- 10. . Exosomes: new players in cell-cell communication. Int. J. Biochem. Cell Biol. 44(11), 2060–2064 (2012).
- 11. . Mesenchymal Stem Cell-Derived Exosomes: Applications in Regenerative Medicine. Cells 10(8), 1959 (2021).
- 12. . Mesenchymal stem cell exosome ameliorates reperfusion injury through proteomic complementation. Reg. Med. 8(2), 197–209 (2013). • Evidence supports that mesenchymal stem cell-derived exosomes can alleviate tissue I/R injury.
- 13. Adipose mesenchymal stem cell-derived exosomes stimulated by hydrogen peroxide enhanced skin flap recovery in ischemia-reperfusion injury. Biochem. Biophys. Res. Commun. 500(2), 310–317 (2018).
- 14. . Harnessing the Angiogenic Potential of Stem Cell-Derived Exosomes for Vascular Regeneration. Stem Cells Int. 2016, 3409169 (2016).
- 15. . Exosomes from adipose-derived mesenchymal stem cells prevent cardiomyocyte apoptosis induced by oxidative stress. Cell Death Discov 5, 79 (2019).
- 16. Combination therapy with melatonin, stem cells and extracellular vesicles is effective in limiting renal ischemia-reperfusion injury in a rat model. Int. J. Urol. 27(11), 1039–1049 (2020).
- 17. Potential Effect of Exosomes Derived from Cancer Stem Cells and MSCs on Progression of DEN-Induced HCC in Rats. Stem Cells Int. 2018, 8058979 (2018).
- 18. The Unique Immunomodulatory Properties of MSC-Derived Exosomes in Organ Transplantation. Front. Immunol. 12, 659621 (2021).
- 19. Pravastatin induces rat aortic endothelial cell proliferation and migration via activation of PI3K/Akt/mTOR/p70 S6 kinase signaling. J. Pharmacol. Sci. 105(4), 334–341 (2007).
- 20. Akt1 in endothelial cell and angiogenesis. Cell Cycle 5(5), 512–518 (2006).
- 21. . Role of Akt signaling in vascular homeostasis and angiogenesis. Circ. Res. 90(12), 1243–1250 (2002).
- 22. . 15(S)-hydroxyeicosatetraenoic acid induces angiogenesis via activation of PI3K-Akt-mTOR-S6K1 signaling. Cancer Res. 65(16), 7283–7291 (2005).
- 23. Aspirin promotes osteogenic differentiation of human dental pulp stem cells. Int. J. Mol. Med. 42(4), 1967–1976 (2018).
- 24. Tendon stem cell-derived exosomes regulate inflammation and promote the high-quality healing of injured tendon. Stem Cell Res. Ther. 11(1), 402 (2020).
- 25. Exosomes derived from human amniotic epithelial cells accelerate wound healing and inhibit scar formation. J. Mol. Histol. 48(2), 121–132 (2017).
- 26. Hypoxic ucMSC-secreted exosomal miR-125b promotes endothelial cell survival and migration during wound healing by targeting TP53INP1. Mol. Ther. Nucleic Acids 26, 347–359 (2021). •• Stem cell-derived exosomes promote endothelial cell proliferation and migration during wound healing.
- 27. . Exosomes of bone-marrow stromal cells inhibit cardiomyocyte apoptosis under ischemic and hypoxic conditions via miR-486-5p targeting the PTEN/PI3K/AKT signaling pathway. Thromb. Res. 177, 23–32 (2019).
- 28. . A novel model for supermicrosurgery training: the superficial inferior epigastric artery flap in rats. J. Reconstr. Microsurg. 24(8), 537–543 (2008).
- 29. . The rat groin flap model redesigned for evaluating treatment effects on ischemia-reperfusion injury. J. Surg. Res. 222, 160–166 (2018). • A rat flap model with ischemia-reperfusion injury.
- 30. Adipose-Derived Stem Cells Protect Skin Flaps against Ischemia/Reperfusion Injury via IL-6 Expression. J. Invest. Dermatol. 137(6), 1353–1362 (2017).
- 31. . Exosomes with Highly Angiogenic Potential for Possible Use in Pulp Regeneration. J. Endod. 44(5), 751–758 (2018).
- 32. . Ischemia and reperfusion--from mechanism to translation. Nat. Med. 17(11), 1391–1401 (2011).
- 33. . Review: ischaemia-reperfusion injury in flap surgery. J. Plast. Reconstr. Aesthet. Surg. 62(6), 721–726 (2009).
- 34. . Challenges and Controversies in Human Mesenchymal Stem Cell Therapy. Stem Cells Int. 2019, 9628536 (2019).
- 35. . Potential therapeutic roles of stem cells in ischemia-reperfusion injury. Stem Cell Res. 37, 101421 (2019).
- 36. Combination of adipose-derived mesenchymal stem cells (ADMSC) and ADMSC-derived exosomes for protecting kidney from acute ischemia–reperfusion injury. Int. J. Cardiol. 216, 173–185 (2016).
- 37. Stroke treatment: is exosome therapy superior to stem cell therapy? Biochimie 179, 190–204 (2020).
- 38. Exosomes From Adipose-Derived Stem Cells: The Emerging Roles and Applications in Tissue Regeneration of Plastic and Cosmetic Surgery. Front. Cell. Dev. Biol. 8, 574223 (2020).
- 39. Mesenchymal stem cell exosomes enhance periodontal ligament cell functions and promote periodontal regeneration. Acta Biomater. 89, 252–264 (2019).
- 40. . Directional cell movement through tissues is controlled by exosome secretion. Nat. Commun. 6, 7164 (2015).
- 41. Exosomes derived from human adipose mensenchymal stem cells accelerates cutaneous wound healing via optimizing the characteristics of fibroblasts. Sci. Rep. 6, 32993 (2016).
- 42. Exosomes released from human induced pluripotent stem cells-derived MSCs facilitate cutaneous wound healing by promoting collagen synthesis and angiogenesis. J. Transl. Med. 13, 49 (2015). • Evidence supports that mesenchymal stem cell-derived exosomes have angiogenic effects.
- 43. Adjudin-preconditioned neural stem cells enhance neuroprotection after ischemia reperfusion in mice. Stem Cell Res. Ther. 8(1), 248 (2017).
- 44. . Protective effects of primary neural stem cell treatment in ischemic stroke models. Exp. Ther. Med. 16(3), 2219–2228 (2018).
- 45. Exosomes/tricalcium phosphate combination scaffolds can enhance bone regeneration by activating the PI3K/Akt signaling pathway. Stem Cell Res. Ther. 7(1), 136 (2016).
- 46. Mesenchymal stem cell-derived exosomes increase ATP levels, decrease oxidative stress and activate PI3K/Akt pathway to enhance myocardial viability and prevent adverse remodeling after myocardial ischemia/reperfusion injury. Stem Cell Res. 10(3), 301–312 (2013). •• Evidence supports that mesenchymal stem cell-derived exosomes reduce I/R damage by activating the PI3K/AKT signaling pathway.
- 47. Bone mesenchymal stem cell-derived exosomal microRNA-29b-3p prevents hypoxic-ischemic injury in rat brain by activating the PTEN-mediated Akt signaling pathway. J. Neuroinflammation 17(1), 46 (2020).
- 48. . TOR signaling in growth and metabolism. Cell 124(3), 471–484 (2006).
- 49. . When translation meets transformation: the mTOR story. Oncogene 25(48), 6423–6435 (2006).
- 50. . p70 S6 kinase in the control of actin cytoskeleton dynamics and directed migration of ovarian cancer cells. Oncogene 30(21), 2420–2432 (2011).
- 51. . AKT signaling in regulating angiogenesis. Curr. Cancer Drug Targets 8(1), 19–26 (2008).
- 52. . Signal transduction by vascular endothelial growth factor receptors. Cold Spring Harb. Perspect. Med. 2(7), a006502 (2012).
- 53. . The key regulatory roles of the PI3K/Akt signaling pathway in the functionalities of mesenchymal stem cells and applications in tissue regeneration. Tissue Eng. Part B Rev. 19(6), 516–528 (2013).
- 54. Prevascularized mesenchymal stem cell-sheets increase survival of random skin flaps in a nude mouse model. Am. J. Transl. Res. 11(3), 1403–1416 (2019).
- 55. Intravenous Infusion of Mesenchymal Stem Cells Promotes the Survival of Random Pattern Flaps in Rats. Plast. Reconstr. Surg. 148(4), 799–807 (2021).
- 56. Chitosan hydrogel incorporated with dental pulp stem cell-derived exosomes alleviates periodontitis in mice via a macrophage-dependent mechanism. Bioact. Mater. 5(4), 1113–1126 (2020).
- 57. Dental pulp stem cell-derived exosomes alleviate cerebral ischaemia-reperfusion injury through suppressing inflammatory response. Cell Prolif. 54(8), e13093 (2021).
- 58. . Role of Exosomes in Dermal Wound Healing: A Systematic Review. J. Invest. Dermatol. 142(3 Pt A), 662–678.e8 (2022).
- 59. . Preclinical efficacy of stem cell therapy for skin flap: a systematic review and meta-analysis. Stem Cell Res. Ther. 12(1), 28 (2021).
- 60. . Akt in ischemia and reperfusion. J. Invest. Surg. 20(3), 195–203 (2007).
- 61. . Role of the PI3K/Akt signaling pathway in liver ischemia reperfusion injury: a narrative review. Ann. Palliat. Med. 11(2), 806–817 (2022).
- 62. . Inhibition of Myocardial Cell Apoptosis Is Important Mechanism for Ginsenoside in the Limitation of Myocardial Ischemia/Reperfusion Injury. Front Pharmacol 13, 806216 (2022).
- 63. . Effects of SB202190 on expression levels of IL-6 and NF-κB in flap ischemia-reperfusion injury. Exp. Ther. Med. 16(3), 2522–2526 (2018).